Model 1 | Model 2 | |||||
---|---|---|---|---|---|---|
Odds ratio | 95% CI | p-value | Odds ratio | 95% CI | p-value | |
ADL Hierarchy | ||||||
0 (Independent) | Reference | Reference | ||||
1 (Supervision) | 1.238 | 1.14–1.35 | <.001 | 1.427 | 1.22–1.69 | <.001 |
2 (Limited) | 2.723 | 2.54–2.92 | <.001 | 2.232 | 1.99–2.50 | <.001 |
3 (Extensiv 1) | 4.701 | 4.39–5.04 | <.001 | 3.293 | 2.95–3.68 | <.001 |
4 (Extensiv 2) | 6.209 | 5.71–6.76 | <.001 | 3.831 | 3.29–4.46 | <.001 |
5 (Dependent) | 7.364 | 6.74–8.05 | <.001 | 4.353 | 3.72–5.09 | <.001 |
6 (Total dependence) | 16.598 | 10.3–26.9 | <.001 | 30.25 | 3.70–248 | 0.001 |
Cognitive performance scale | ||||||
0 (Intact) | Reference | Reference | ||||
1 (Borderline Intact) | 1.619 | 1.52–1.72 | <.001 | 1.349 | 1.18–1.54 | <.001 |
2 (Mild Impairment) | 2.217 | 2.07–2.37 | <.001 | 1.406 | 1.21–1.63 | <.001 |
3 (Moderate Impairment) | 2.975 | 2.78–3.19 | <.001 | 1.287 | 1.05–1.59 | 0.170 |
4 (Mod. Severe Impairment) | 4.990 | 4.36–5.72 | <.001 | 1.338 | 0.48–3.70 | 0.575 |
5 (Severe Impairment) | 6.902 | 6.20–7.68 | <.001 | 1.599 | 0.74–3.46 | 0.233 |
6 (Very Severe Impairment) | 12.593 | 7.31–21.7 | <.001 | 5.988 | 0.68–52.5 | 0.106 |
Age | ||||||
65– 74 | Reference | Reference | ||||
75 – 84 | 1.201 | 1.11–1.30 | <0.001 | 1.189 | 1.10–1.29 | <0.001 |
85 – 94 | 1.452 | 1.34–1.57 | <0.001 | 1.409 | 1.30–1.53 | <0.001 |
> 94 | 1.754 | 1.56–1.97 | <0.001 | 1.677 | 1.49–1.89 | <0.001 |
Comorbidities (Reference not diseased) | ||||||
Diabetes Mellitus | 1.189 | 1.12–1.26 | <0.001 | 1.181 | 1.12–1.25 | <0.001 |
Arthrose/Arthritis | 1.530 | 1.10–1.21 | <0.001 | 1.155 | 1.10–1.21 | <0.001 |
Dementia | 1.090 | 1.04–1.16 | <0.001 | 1.107 | 1.05–1.17 | <0.001 |